These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. [Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina]. Chaves M; Bettini M; Marciano S; Sáez S; Cristiano E; Rugiero M Medicina (B Aires); 2016; 76(2):105-8. PubMed ID: 27135849 [TBL] [Abstract][Full Text] [Related]
32. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Munar-Qués M; Salva-Ladaria L; Mulet-Perera P; Solé M; López-Andreu FR; Saraiva MJ Amyloid; 2000 Dec; 7(4):266-9. PubMed ID: 11132095 [TBL] [Abstract][Full Text] [Related]
33. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Ikeda S; Nakazato M; Ando Y; Sobue G Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682 [TBL] [Abstract][Full Text] [Related]
34. Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers. Sousa MM; Ferrão J; Fernandes R; Guimarães A; Geraldes JB; Perdigoto R; Tomé L; Mota O; Negrão L; Furtado AL; Saraiva MJ Lab Invest; 2004 Jul; 84(7):865-73. PubMed ID: 15122304 [TBL] [Abstract][Full Text] [Related]
35. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation. Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715 [TBL] [Abstract][Full Text] [Related]
36. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP). Ando Y Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043 [TBL] [Abstract][Full Text] [Related]
37. Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients. Ikeda S Clin Chem Lab Med; 2002 Dec; 40(12):1257-61. PubMed ID: 12553427 [TBL] [Abstract][Full Text] [Related]
38. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation. Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946 [TBL] [Abstract][Full Text] [Related]
39. Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study. Planté-Bordeneuve V; Gorram F; Salhi H; Nordine T; Ayache SS; Le Corvoisier P; Azoulay D; Feray C; Damy T; Lefaucheur JP J Neurol; 2017 Feb; 264(2):268-276. PubMed ID: 27878441 [TBL] [Abstract][Full Text] [Related]
40. Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment. Ikeda T; Masuda T; Ueda M; Yamashita T; Misumi Y; Shinriki S; Ando Y Ann Clin Biochem; 2018 Sep; 55(5):571-575. PubMed ID: 29310464 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]